93805-89-1 Usage
Description
Isopropyl DL-methionate hydrochloride is a chemical compound that combines isopropyl, an alcohol with antiseptic properties and solvent uses, DL-methionate, an amino acid involved in sulfur-containing amino acid metabolism, and hydrochloride, which enhances the solubility and stability of the compound. This unique combination of properties may contribute to its potential applications in various industries.
Uses
Used in Pharmaceutical Industry:
Isopropyl DL-methionate hydrochloride is used as an active pharmaceutical ingredient for its potential therapeutic effects, leveraging its antiseptic properties and involvement in amino acid metabolism for the development of new medications.
Used in Personal Care Products:
Isopropyl DL-methionate hydrochloride is used as a key component in personal care products for its antiseptic properties, helping to maintain hygiene and prevent infections, particularly in products such as sanitizers and skincare formulations.
Used in Industrial Processes:
Isopropyl DL-methionate hydrochloride is used as a versatile solvent and stabilizing agent in various industrial applications, taking advantage of its solubility and stability-enhancing properties to improve the performance and quality of different products.
Check Digit Verification of cas no
The CAS Registry Mumber 93805-89-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,8,0 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 93805-89:
(7*9)+(6*3)+(5*8)+(4*0)+(3*5)+(2*8)+(1*9)=161
161 % 10 = 1
So 93805-89-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H17NO2S.ClH/c1-6(2)11-8(10)7(9)4-5-12-3;/h6-7H,4-5,9H2,1-3H3;1H
93805-89-1Relevant articles and documents
-
Brenner,Kocher
, p. 333,335 (1949)
-
Inhibitors of farnesyl-protein transferase
-
, (2008/06/13)
The present invention comprises analogs of the CAAX motif of the protein Ras that is modified by farnesylation in vivo. These CAAX analogs inhibit farnesyl-protein transferase. Furthermore, these CAAX analogues differ from those previously described as inhibitors of farnesyl-protein transferase in that they do not have a thiol moiety. The lack of the thiol offers unique advantages in terms of improved pharmacokinetic behavior in animals, prevention of thiol-dependent chemical reactions, such as rapid autoxidation and disulfide formation with endogenous thiols, and reduced systemic toxicity. Further contained in this invention are chemotherapeutic compositions containing these farnesyl transferase inhibitors and methods for their production.
INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE
-
, (2008/06/13)
The present invention comprises analogs of the CAAX motif of the protein Ras that is modified by farnesylation in vivo. These CAAX analogs inhibit farnesyl-protein transferase. Furthermore, these CAAX analogues differ from those previously described as inhibitors of farnesyl-protein transferase in that they do not have a thiol moiety. The lack of the thiol offers unique advantages in terms of improved pharmacokinetic behavior in animals, prevention of thiol-dependent chemical reactions, such as rapid antoxidation and disulfide formation with endogenous thiols, and reduced systemic toxicity. Further contained in this invention are chemotherapeutic compositions containing these farnesyl transferase inhibitors and methods for their production.
